Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Sounds of Tolerance
4 June 2026
Upcoming Talks
Where have all the blackbirds gone: The UK's first mosquito-borne viral zoonosis
Monday, 15 June 2026, 1.30pm to 2.30pm
Connect@CHG Genomics Data Forum: "Decoding immune cell interactions under therapeutic modulation using Teton Cytoprofiling"
Tuesday, 16 June 2026, 10am to 10.30am
Targeting prolylcarboxypeptidase-mediated autophagy for cardiac protection
Tuesday, 16 June 2026, 12pm to 1pm
Primary aldosteronism: molecular medicine meets public health
Wednesday, 17 June 2026, 12.45pm to 2pm
Finding Your Place: Transcription Factors as Sensors and Modifiers of Chromatin
Thursday, 18 June 2026, 12pm to 1pm
Latest publications
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Spatio-temporal eco-evolutionary dynamics of prey-predator systems with defended and undefended prey
Preprint
Roy S. et al, (2026)